about
Mutation screening of the MAPT and STH genes in Polish patients with clinically diagnosed frontotemporal dementiaStrong association between Saitohin gene polymorphism and tau haplotype in the Polish populationCYP46: a risk factor for Alzheimer's disease or a coincidence?Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseaseConformational altered p53 as an early marker of oxidative stress in Alzheimer's diseaseA patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene.Mitochondrial haplogroup H and Alzheimer's disease--is there a connection?LRRTM3 interacts with APP and BACE1 and has variants associating with late-onset Alzheimer's disease (LOAD).A novel MAPT mutation, G55R, in a frontotemporal dementia patient leads to altered Tau function.Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control studyDNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients.PARK2 variability in Polish Parkinson's disease patients--interaction with mitochondrial haplogroups.Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications.Assessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olfactory DysfunctionMitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disordersA multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants.Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactionsTREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's diseaseAgraphia in patients with frontotemporal dementia and parkinsonism linked to chromosome 17 with P301L MAPT mutation: dysexecutive, aphasic, apraxic or spatial phenomenon?Radiological Evaluation of Strategic Structures in Patients with Mild Cognitive Impairment and Early Alzheimer's Disease.ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease.The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study.Is descriptive writing useful in the differential diagnosis of logopenic variant of primary progressive aphasia, Alzheimer's disease and mild cognitive impairment?Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease.Cell cycle regulation distinguishes lymphocytes from sporadic and familial Alzheimer's disease patients.Writing in Richardson variant of progressive supranuclear palsy in comparison to progressive non-fluent aphasia.Intra-familial clinical heterogeneity due to FTLD-U with TDP-43 proteinopathy caused by a novel deletion in progranulin gene (PGRN).Hypertension in patients with Alzheimer's disease--prevalence, characteristics, and impact on clinical outcome. Experience of one neurology center in Poland.Increased CD44 gene expression in lymphocytes derived from Alzheimer disease patients.The E318G substitution in PSEN1 gene is not connected with Alzheimer's disease in a large Polish cohort.Earlier onset of Alzheimer's disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes.TOMM40 and APOE common genetic variants are not Parkinson's disease risk factors.DNA methylation in ELOVL2 and C1orf132 correctly predicted chronological age of individuals from three disease groups.Magnetic resonance imaging-based hippocampal volumetry in patients with dementia of the Alzheimer type.Frontotemporal dementia: An attempt at clinical characteristics.Combined use of biochemical and volumetric biomarkers to assess the risk of conversion of mild cognitive impairment to Alzheimer's disease.Microglia is a component of the prion protein amyloid plaque in the Gerstmann-Sträussler-Scheinker syndrome.Prevalence of major and minor depression in elderly persons with mild cognitive impairment--MADRS factor analysis.Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.Changes in amyloid precursor protein and apolipoprotein E immunoreactivity following ischemic brain injury in rat with long-term survival: influence of idebenone treatment.
P50
Q28182196-998ABC16-FB47-4C2D-8E14-614815889DC8Q28203014-DCBEF143-A866-44AB-A028-5AE25E535FD5Q28254656-37B49168-E208-4E20-8E5A-1F086C5FEA35Q29614879-DA7DAD95-BB15-4CAE-9EE2-4096134C6B29Q34126651-DB4225A0-48BA-403C-AEA6-C0E472136CD5Q34674582-B6BD0E9E-37EB-49E6-BBCC-8366A68735F4Q34756622-E394B06B-294B-44F9-A558-F7B588ED6DABQ34764092-577BED3C-25A9-4EA3-8823-D017AF0366C0Q35006348-C5FBA0C1-604E-4BC9-8681-E5FE0A57D1F4Q35168704-09D97BC0-6103-4DF3-A86E-49EEE1960181Q35972427-B7037A26-B274-4A3E-B208-DF5E3ECC121EQ35981624-7A1BBAEE-2868-4BC4-A1CE-802FF359EC4BQ36086872-2B7CE21C-8B83-440F-B73E-01CCCE11AE71Q36195000-FF691538-C54D-487D-B2E6-884AA91C333EQ36365785-EBC73B98-A547-4AFC-9792-D2101877A94DQ36370223-7EA50427-A1D3-48E2-ADAF-51DC99AAB984Q36371829-F4C2AE63-A9A0-4E25-861C-5DDDFB52044DQ36952445-5E90B08D-F38B-426B-8703-E2EA5E1554F1Q37008922-836305B7-FCC3-4A9A-A8DE-FCC04901BEBFQ37028527-25754E77-14B7-4889-B266-102699C74C63Q37716948-6C70F3DC-9185-430C-89DD-E619902706E8Q38116350-41F3C040-40CE-4C40-BE21-C3F59B9FC764Q38407732-1A46A239-C92A-4845-AACD-E3851F9D3AFBQ39638549-6E18E820-68D4-4C4E-B774-EB5F606850D3Q39694131-72D61D9C-EBA0-4C98-A252-2122822DFBE6Q40721136-EEAF9CD6-F934-480A-86EF-31FF75F39898Q41259318-EF851C35-ABBB-4B8E-A3D4-87B8978D5153Q41547879-9DED5EB0-609D-4E16-9E38-36CA1603AD6FQ43144593-B6DB9C51-536A-4311-A82C-6A3F07CB24D3Q44787942-4756A282-9CCE-408C-ACD7-5AEF5107C2AFQ46052723-50000858-BFA6-46BC-A597-6B8189C04162Q46224357-1EC46BD8-F094-4ACC-AFF1-1FEBE865ED49Q47758996-EE4FE061-1BE2-4DE4-8536-BBB631E27A7DQ48189587-052AB5B6-7039-4E5C-B341-F07CD4F0B4CBQ48212622-D376AD4B-5D53-46A9-80A8-76AD37199D98Q48331908-DA8E1FDF-5C15-4984-B4CB-D54C6E384361Q48374047-DEB30716-F8CA-4A3B-AD58-23572422B719Q48574837-1CEA551A-8DEF-46B4-B2CA-97D27EED105CQ48596415-A3027D4E-68EB-4A67-AA44-79D5CB6D070DQ48634573-0BF0DC4C-56FA-4E53-B4B4-CBCE88E7B569
P50
description
researcher ORCID ID = 0000-0001-5657-9670
@en
wetenschapper
@nl
name
Maria Barcikowska
@ast
Maria Barcikowska
@en
Maria Barcikowska
@es
Maria Barcikowska
@nl
type
label
Maria Barcikowska
@ast
Maria Barcikowska
@en
Maria Barcikowska
@es
Maria Barcikowska
@nl
prefLabel
Maria Barcikowska
@ast
Maria Barcikowska
@en
Maria Barcikowska
@es
Maria Barcikowska
@nl
P214
P106
P108
P1153
6603158364
7006054094
P21
P214
P31
P496
0000-0001-5657-9670
P735
P7859
viaf-101836468